Table 5

Results of meta-analysis in different statins groups
   Group Included arms (and case) Pooled SMD (95% CI, p ) Heterogeneity test Sensitivity analyses Egger’s test
χ2test ( p ) I2 Lower SMD (95% CI) Upper SMD (95% CI)
Rosuvastatin 5 (1173) -0.162 (-0.234~ -0.081, 0.000) 0.37 (0.985) 0 -0.153 (-0.249~-0.056) -0.178 (-0.287~-0.069) 0.770
Without 2006 ASTEROID Ros Without 2011 SATURN Ros
Atorvastatin 8 (1138) -0.101 (-0.184~ -0.019, 0.016) 4.44 (0.728) 0 -0.075 (-0.162~0.012) -0.132 (-0.225~-0.038) 0.582
Without 2009 JAPAN-ACS Ato Without 2004 REVERSAL Ato
Pitavastatin 1 (125) -0.304 (-0.553~-0.055, 0.017)
Fluvastatin 1 (40) -0.169 (-0.608~0.270, 0.450)
Simvastatin 2 (90) -0.10 (-0.393~ 0.192, 0.501) 0.04 (0.846) 0 -0.074 (-0.467~0.318) -0.133 (-0.572~0.360) 0.000
Without 2004 Jensen LO Sim Without 2009 Hong MK Sim
Pravastatin 3 (319) -0.008 (-0.163~0.147, 0.920) 1.86 (0.395) 0 -0.005 (-0.165~0.154) 0.039 (-0.131~0.208) 0.528
Without 2005 Kawasaki M Pra Without 2005 Tani S Pra

Gao et al.

Gao et al. BMC Cardiovascular Disorders 2014 14:60   doi:10.1186/1471-2261-14-60

Open Data